Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron vs ondansetron for prevention of intrathecal morphine-induced postoperative nausea, vomiting, and pruritus in cesarean delivery
TCTR20210611005Phase 4Completed
- Sponsor
- King Chulalongkorn Memorial Hospital
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of palonosetron, ondansetron in postoperative nausea and vomiting (PONV), pruritus, sponsored by King Chulalongkorn Memorial Hospital. Started Jun 2021; status: completed.
02
Drugs
palonosetronondansetron
03
Conditions
postoperative nausea and vomiting (PONV)pruritus
Beyond the preview
Go deeper on TCTR20210611005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210611005.